Investment details
- Closing date
- 27/03/26
- Fundraise target
- £175,000
- Fundraise maximum
- £350,000
- Minimum investment
- £5,000
- Equity stake
- 7.9%
- Exit Money Multiple
- Log in to view
- Exit IRR
- Log in to view
Body Rocket is a next-generation cycling performance system that delivers real-time aerodynamic and biomechanical insights — technology previously accessible only to elite teams using expensive wind tunnels. Visit their website here.
Designed for cyclists and triathletes, the bike-mounted platform uses four precision sensors to measure how efficiently a rider moves through the air and applies power on real roads. The system provides actionable data on position, equipment and technique without the need for specialist facilities - all at a price point accessible to serious amateur athletes.
Current users include Olympians, elite cycling teams and world champions, including Kristian Blummenfelt (World,Olympic and Ironman champion).
Body Rocket is targeting the$4.5bn global cycling tech market, with longer-term expansion into adjacent markets including physical rehabilitation and e-sports. It is the only system combining power, aerodynamics and biomechanics into a single unified dataset —offering insights that no direct competitor currently provides.
The company is now raising£750k (EIS-qualifying) at a £4.7m pre-money valuation. Proceeds will fund key sales hires, manufacturing scale-up and the development of in-house technology capability to accelerate commercialisation. We are pleased to have secured an allocation of up to £350k for our investors.
BodyRocket delivers real-time aerodynamic insights previously accessible only to elite teams. A compact, bike-mounted system replaces wind-tunnel testing by capturing high-quality aerodynamic data on every outdoor ride to prevent injurie and deliver significant performance gains.
We empower investors to stay in control of their capital, choose the companies they back and share in their journey to success.
Unlike most VCs, we are not a fund — we combine institutional-grade diligence and attractive tax benefits with the opportunity to co-invest alongside some of the UK’s leading VC firms.
Body Rocket is a next-generation cycling performance system that delivers real-time aerodynamic and biomechanical insights — technology previously accessible only to elite teams using expensive wind tunnels. Visit their website here.
Designed for cyclists and triathletes, the bike-mounted platform uses four precision sensors to measure how efficiently a rider moves through the air and applies power on real roads. The system provides actionable data on position, equipment and technique without the need for specialist facilities - all at a price point accessible to serious amateur athletes.
Current users include Olympians, elite cycling teams and world champions, including Kristian Blummenfelt (World,Olympic and Ironman champion).
Body Rocket is targeting the$4.5bn global cycling tech market, with longer-term expansion into adjacent markets including physical rehabilitation and e-sports. It is the only system combining power, aerodynamics and biomechanics into a single unified dataset —offering insights that no direct competitor currently provides.
The company is now raising£750k (EIS-qualifying) at a £4.7m pre-money valuation. Proceeds will fund key sales hires, manufacturing scale-up and the development of in-house technology capability to accelerate commercialisation. We are pleased to have secured an allocation of up to £350k for our investors.
BodyRocket delivers real-time aerodynamic insights previously accessible only to elite teams. A compact, bike-mounted system replaces wind-tunnel testing by capturing high-quality aerodynamic data on every outdoor ride to prevent injurie and deliver significant performance gains.

The Enterprise Investment Scheme (EIS) lets UK investors back growth companies with tax relief. Benefits include up to 30% income tax relief, plus Capital Gains, loss and Inheritance Tax advantages.
We want our investors to be fully aware of the downsides of investing as well as the potential benefits. It's therefore important to realise that investing always carries risks, including the loss of capital, illiquidity (the inability to sell assets quickly or without substantial loss in value), lack of dividends and share dilution. Alternative investments should still be made as part of a diversified portfolio.